Andorra vs South America: Proportion of the target population who received a 3rd dose of
Andorra
96.0%
in 2024
South America
77.0%
in 2024
Andorra rank
16th
South America rank
16th
Proportion of the target population who received a 3rd dose of over time
- Andorra
- South America
How they compare
Andorra currently reports 96.0% against 77.0% in South America, a difference of 19.0%.
That makes Andorra's figure about 1.2 times South America's.
Across all 11 years both countries report, Andorra has been ahead every year.
Andorra ranks 16th and South America ranks 16th of 157 countries.
Andorra has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | South America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 94.2% | 78.7% | 15.5% | Andorra |
| 2020s | 95.2% | 71.6% | 23.6% | Andorra |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Andorra or South America?
- Andorra, at 96.0% against 77.0% in South America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Andorra and South America?
- 19.0%, with Andorra ahead.
- How many years of comparable data are there for Andorra and South America?
- 11 years are reported by both, from 2014 to 2024.
- How do Andorra and South America rank globally for proportion of the target population who received a 3rd dose of?
- Andorra ranks 16th and South America ranks 16th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.